Tembexa
NDC 64678-012, Brincidofovir, suspension, from Emergent BioDefense Operations Lansing LLC.
- Product NDC
- 64678-012
- Status
- Listed
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214460
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64678-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRINCIDOFOVIR10 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64678-012-01 | 64678001201 | 65 mL in 1 BOTTLE (64678-012-01) |
| 64678-012-02 | 64678001202 | 65 mL in 1 BOTTLE (64678-012-02) |
| 64678-012-03 | 64678001203 | 1 BOTTLE in 1 CARTON (64678-012-03) / 45 mL in 1 BOTTLE |
| 64678-012-04 | 64678001204 | 1 BOTTLE in 1 CARTON (64678-012-04) / 45 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0784838e-00bd-4b14-9b7e-653b7fbb7eea
Use it
Look up 64678-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64678-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64678-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.